SCHEMBL14065670

SCHEMBL14065670

CC(C)NC(=O)[C@H](N)CCCCN

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 6/20 0.58
DPP8 Q6V1X1 5/20 0.58
DPP9 Q86TI2 5/20 0.58
GNAI3 P08754 1/20 0.54
GNAO1 P09471 1/20 0.54
GNAI1 P63096 1/20 0.54
GSR P00390 1/20 0.53
DPP4 P27487 2/20 0.51
SLC15A1 P46059 1/20 0.44
MMP2 P08253 1/20 0.43
TLR2 O60603 1/20 0.42
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14065666 1.00 DPP7 (0.58) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL18633064 1.00 DPP7 (0.58) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL19080499 0.94 DPP7 (0.57) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL5079730 0.89 DPP8 (0.58) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL3485077 0.89 DPP7 (0.58) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL18714213 0.87 DPP7 (0.56) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL13829054 0.85 DPP7 (0.45) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL25761063 0.85 DPP7 (0.58) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL9705058 0.84 GSR (0.58) DPP7DPP8DPP9GNAI3GNAO1
SCHEMBL2115368 0.84 GSR (0.58) DPP7DPP8DPP9GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7419990-B2 Piperidine derivatives as melanocortin-4 receptor agonists MERCK & CO., INC. (US) 2008-09-02 US disclosed
US-7419990-B2 Piperidine derivatives as melanocortin-4 receptor agonists MERCK & CO., INC. (US) 2008-09-02 US disclosed